Neuren Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	64.63	136.73	231.93	14.55	-
Other Revenue	0.02	80.11	0.02	0.86	3.2
Revenue	64.65	216.83	231.94	15.42	3.2
Revenue Growth (YoY)	-70.19%	-6.51%	1404.46%	382.23%	345.89%
Cost of Revenue	36.39	32.97	26.75	12.71	9.52
Gross Profit	28.26	183.86	205.19	2.71	-6.32
Selling, General & Admin	6.22	4.7	5.95	3.44	1.91
Operating Expenses	6.22	4.7	5.95	3.44	1.91
Operating Income	22.04	179.16	199.25	-0.73	-8.23
Interest & Investment Income	12.16	11.01	5.69	0.39	0.04
Currency Exchange Gain (Loss)	8.03	-7.24	2.43	1.23	0.4
Other Non Operating Income (Expenses)	-3.3	-	-2.23	-0.7	-
EBT Excluding Unusual Items	38.93	182.94	205.14	0.18	-7.79
Pretax Income	38.93	182.94	205.14	0.18	-7.79
Income Tax Expense	8.49	40.9	48.06	-	-
Net Income	30.44	142.04	157.08	0.18	-7.79
Net Income to Common	30.44	142.04	157.08	0.18	-7.79
Net Income Growth	-78.57%	-9.57%	85270.11%	-	-
Shares Outstanding (Basic)	128	128	127	126	118
Shares Outstanding (Diluted)	131	131	131	129	119
Shares Change (YoY)	-0.01%	0.01%	1.44%	8.76%	10.71%
EPS (Basic)	0.24	1.11	1.24	0.00	-0.07
EPS (Diluted)	0.23	1.09	1.20	0.00	-0.07
EPS Growth	-78.57%	-9.58%	120020.00%	-	-
Free Cash Flow	125.39	-11.28	184.89	3.58	-9.98
Free Cash Flow Per Share	0.96	-0.09	1.41	0.03	-0.08
Gross Margin	43.71%	84.80%	88.47%	17.55%	-197.65%
Operating Margin	34.09%	82.63%	85.90%	-4.75%	-257.52%
Profit Margin	47.08%	65.51%	67.72%	1.19%	-243.79%
Free Cash Flow Margin	193.95%	-5.20%	79.71%	23.22%	-312.17%
EBITDA	22.06	179.18	199.26	-0.72	-8.23
EBITDA Margin	34.13%	82.64%	85.91%	-4.68%	-257.27%
D&A For EBITDA	0.02	0.02	0.02	0.01	0.01
EBIT	22.04	179.16	199.25	-0.73	-8.23
EBIT Margin	34.09%	82.63%	85.90%	-4.75%	-257.52%
Effective Tax Rate	21.82%	22.36%	23.43%	-	-
Revenue as Reported	84.84	227.85	240.06	17.03	3.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.